Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Jul 20, 2022
Wednesday Jul 20, 2022
touchCONGRESS for touchONCOLOGY
Listen to Professor Giuseppe Saglio (Italy) cover key data presented at the EHA Hybrid Conference 2022 on the efficacy and safety of current and emerging treatments for CML, and how these may influence clinical practice, as well as expert insights and interpretation from Professor François-Xavier Mahon (France) and Professor Dietger Niederwieser (Germany).
Overview
- Data review with Professor Giuseppe Saglio (00:54)
- Expert interview with Professor Giuseppe Saglio, Professor François-Xavier Mahon and Professor Dietger Niederwieser (32:50)
Interview questions
- When considering the new 96-week data for asciminib from the ASCEMBL trial, how do you think these results will impact clinical practice? (35:00)
- In patients with absence of an optimal response on therapy, what can we learn from new data on switching TKIs? (41:00)
- What have we learnt about the clinical considerations for TKI discontinuation?(47:09)
- Extended use of TKIs is now commonplace; what safety aspects have we seen from long-term follow-up studies?(52:26)
- How should dose modifications be used for TKIs in clinical practice? (57:39)
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Novartis Pharmaceuticals. This activity is provided by touchIME.
For further information visit our website: www.touchoncology.com
Tuesday Jul 19, 2022
Tuesday Jul 19, 2022
touchIN CONVERSATION for touchONCOLOGY
Listen to gynaecologic oncology specialists Prof. Nicoletta Colombo and Dr Natalia R Gómez-Hidalgo discuss three key topics relating to PARP inhibitors in the first-line maintenance setting for advanced ovarian cancer – rationale for use, which patients may particularly benefit, and key factors informing PARP inhibitor selection.
Discussion on these themes is based on questions posed by healthcare professionals involved in the care of patients with ovarian cancer.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website:
https://touchoncology.com/education/parp-inhibitors-maintenance-inconvo2022/
Friday Jul 08, 2022
Friday Jul 08, 2022
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.
The experts
Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA
Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK
Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: https://touchimmunologyime.org/
Friday Jul 08, 2022
Friday Jul 08, 2022
touchPANEL DISCUSSION for touchRESPIRATORY
Listen to key experts as they discuss the pathophysiology of eosinophilic oesophagitis (EoE) and provide their perspectives on the similarities and differences in its clinical presentation in children vs adults, the transition of care from paediatric to adult services, and the current and future treatment options for patients with EoE.
The experts
Dr Nirmala Gonsalves - Northwestern University Feinberg School of Medicine, Chicago, USA
Dr Sharon Hall - Imperial College Healthcare NHS Trust, London, UK
Dr Salvatore Oliva - Sapienza University of Rome, Rome, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information please visit our website: https://touchrespiratoryime.org/
Thursday Jun 30, 2022
Thursday Jun 30, 2022
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
- Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK
- Prof. Eva Havrdová, General Faculty Hospital, Charles University in Prague, Czech Republic
- Prof. Patrick Vermersch, Lille University Hospital, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
Wednesday Jun 15, 2022
Wednesday Jun 15, 2022
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.
The experts
- Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil
- Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany
- Prof. Chiun-Sheng Huang - National Taiwan University Hospital, Taipei City, Taiwan
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/
Monday Jun 13, 2022
Monday Jun 13, 2022
touchIN CONVERSATION for touchONCOLOGY
Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma.
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Takeda Pharmaceuticals USA Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchoncology.com
Thursday May 26, 2022
Thursday May 26, 2022
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.
The experts
- Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil
- Prof. Joël Guigay - Cancer Center Antoine Lacassagne, Nice, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/
Tuesday May 24, 2022
Tuesday May 24, 2022
touchMDT for touchIMMUNOLOGY
Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.
The multidisciplinary team
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
- Dietitian: Dr Isabel Skypala, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/
Tuesday May 24, 2022
Tuesday May 24, 2022
touchMDT for touchIMMUNOLOGY
Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.
The multidisciplinary team
- Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
- Allergist/immunologist: Prof. Jonathan Spergel, USA
- Dietitian: Dr Isabel Skypala, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/